Tech Company Financing Transactions

Scribe Therapeutics Funding Round

Scribe Therapeutics, operating out of Alameda, secured $100 million from Avoro Capital Advisors, Andreessen Horowitz and OrbiMed.

Transaction Overview

Announced On
3/25/2021
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1150 Marina Village Pkwy.
Alameda, CA 94501
USA
Phone
Undisclosed
Email Address
Overview
Scribe was founded by CRISPR leaders from UC Berkeley with an unmatched expertise and track record in CRISPR and protein engineering. Our unique ability to engineer biology will fundamentally transform how we diagnose, treat, and manage disease at scale.
Profile
Scribe Therapeutics LinkedIn Company Profile
Social Media
Scribe Therapeutics Company Twitter Account
Company News
Scribe Therapeutics News
Facebook
Scribe Therapeutics on Facebook
YouTube
Scribe Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Benjamin Oakes
  Benjamin Oakes LinkedIn Profile  Benjamin Oakes Twitter Account  Benjamin Oakes News  Benjamin Oakes on Facebook
Co-Founder
Jennifer Doudna
  Jennifer Doudna LinkedIn Profile  Jennifer Doudna Twitter Account  Jennifer Doudna News  Jennifer Doudna on Facebook
Co-Founder
David Savage
  David Savage LinkedIn Profile  David Savage Twitter Account  David Savage News  David Savage on Facebook
Vice President
Brett Staahl
  Brett Staahl LinkedIn Profile  Brett Staahl Twitter Account  Brett Staahl News  Brett Staahl on Facebook
VP - Bus. Development
Svetlana Lucas
  Svetlana Lucas LinkedIn Profile  Svetlana Lucas Twitter Account  Svetlana Lucas News  Svetlana Lucas on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/25/2021: WeConvene venture capital transaction
Next: 3/25/2021: 1910 Genetics venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary